Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount

The companies’ new effort would bypass traditional middlemen, including pharmacy benefit managers and insurers, to cut the drug’s monthly cost from a list price of around $606 to $346